Arch Venture Corp »

Generate Biomedicines Ord shares owned by Arch Venture Corp

Quarter-by-quarter ownership of Generate Biomedicines Ord shares owned by Arch Venture Corp from 13F filings

Historical chart of Arch Venture Corp investment in Generate Biomedicines Ord

Tip: Access up to 7 years of quarterly data

All positions including Generate Biomedicines Ord held by Arch Venture Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Generate Biomedicines Ord by Arch Venture Corp

Quarter filed Position value Share count Share price at filing
2026-03-31 $24M 1.9M 12.50

More positions owned by Arch Venture Corp

Maze Therapeatics (MAZE)
Rapport Therapeutics (RAPP)
Vir Biotechnology (VIR)
Erasca (ERAS)
Beam Therapeutics (BEAM)
Lyell Immunopharma Com New (LYEL)
Generate Biomedicines Com Shs
10x Genomics Cl A Com (TXG)
Gossamer Bio (GOSS)
Q32 Bio (QTTB)

View all positions for Arch Venture Corp

Top funds holding Generate Biomedicines Ord

Flagship Ventures Management
Capital World Investors
Braidwell
Arch Venture Corp
Baker Bros. Advisors
Harvard Management Company
Nvidia Corp
Alyeska Investment Group
ARK Investment Management
Millennium Management
UBS Group
Morgan Stanley
ExodusPoint Capital Management
CenterBook Partners
Sphera Funds Management

View all funds holding Generate Biomedicines Ord